CAS: 144-24-1; 2-Amino-2,4-Dimethylpentanoic Acid

该化合物是一种氨酸,以其分支链结构为特征,是一种非极地,疏水化合物,因为甲型碳存在一个甲基组,影响其溶解性和与其他分子的相互作用.这种氨酸存在于D和L两种形式中,DL名称显示两种对应物的种族混合物. -甲基-DL-leucine在表面上一般是白色到非白色的,在水中是溶解的,尽管其溶解性可因pH和温度而不同. 它在各种生物化学过程中发挥作用,并经常用于研究和工业应用,特别是在聚苯酯和蛋白质的合成中.此外,它的结构相似性允许它参与代谢途径,从而引起对营养和生物化学学研究的兴趣.应当参考安全数据,以便处理任何化学物质,确保采取适当的防范措施.

结构式图片

相似化合物

312624-65-0 1231709-23-1 29589-03-5

上下游产品

CAS号27886-67-5 5-甲基-5-(2-甲基丙基)... | CAS号60307-38-2 2-(benzylidenea... | CAS号71680-52-9 tetrabutylammon... | CAS号108-10-1 甲基异丁基甲酮

合成工艺路线路线简述

    📜2-(Benzylideneamino)-2,4-Dimethylpentanenitrile置于盐酸体系中,化学反应生成Dl-Alfa-甲基亮氨酸
    参考文献:Rai,M. Et Al.,Indian Journal Of Chemistry-Section B Organic And Medicinal Chemistry,1979,Vol. 18,P. 273-274
    标题:Rai,M. Et Al.,Indian Journal Of Chemistry-Section B Organic And Medicinal Chemistry,1979,Vol. 18,P. 273-274

    海关参考信息

    专利信息


    专利号:WO-9517903-A1
    优先权日:1993-12-28
    标 题:Modular design and synthesis of oxazolone-derived molecules
    发明人:HOGAN JOSEPH C JR; CASEBIER DAVID; FURTH PAUL; TU CHENG
    权利人:ARQULE PARTNERS L P; HOGAN JOSEPH C JR; CASEBIER DAVID; FURTH PAUL; TU CHENG
    摘要:The design and synthesis of novel oxazolone-derived molecular modules and the use of the modules in the construction of new molecules and fabricated materials is disclosed. The new molecules and fabricated materials are molecular recognition agents useful in the design and synthesis of drugs, and have applications in separations and materials science.

    专利号:WO-2007034064-A1
    优先权日:2005-09-21
    标 题 :Continuous synthesis of an $g(a)-amino acid from a cyanhydrin of $g(a)-amino acid without the isolation of intermediate products
    发明人:CASSE CLAUDE; GUIARD AGNES; MEDARD ALAIN
    权利人:ADISSEO FRANCE SAS; CASSE CLAUDE; GUIARD AGNES; MEDARD ALAIN
    摘要:The invention relates to a method for the continuous preparation of an a-amino acid having general formula (I) from the corresponding cyanhydrin of a-amino acid having general formula (II), in which R and R', which may be identical or different, optionally form a ring and each represent: H; an alkyl, haloalkyl or heteroaryl group containing between 1 and 30 carbon atoms, in a straight or branched chain; an alkenyl or alkynyl group containing between 2 and 30 carbon atoms, in a straight or branched chain; one or more cycloalkyl, cycloakenyl or cycloalkynyl groups containing between 3 and 30 carbon atoms, in a straight or branched chain; one or more aryl or heteroaryl groups containing between 1 and 10 carbon atoms per ring and optionally substituted by R; an alkaryl or aralkyl group containing between 5 and 30 carbon atoms, the terms aryl and alkyl having the definitions above; an alkoxy, alkoxyalkyl, alkylthioalkyl, alkylsulfonylalkyl, alkylaminoalkyl group containing between 1 and 30 carbon atoms, in a straight or branched chain; an alkoxyaryl group containing between 5 and 10 carbon atoms; one or more heterocyclic groups containing between 5 and 10 carbon atoms per ring; or a combination of one or more of the above groups, said groups being optionally substituted by R, by one or more nitro, cyano, hydroxy, carboxy, carbonyl or amino groups, by one or more halogens or by one or more nitrile, cyanhydrin, aldehyde functions. According to the invention: when R and R' together form a ring, said ring is as defined above; when R represents H, R' is different from H; and when R' represents H, R is different from H.

    专利号:US-2023037284-A9
    优先权日:2018-11-30
    标题:Combination therapy of peptidomimetic macrocycles
    发明人:GUERLAVAIS VINCENT; ANNIS DAVID ALLEN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    专利号:WO-2025052429-A1
    优先权日:2023-09-04
    标 题 :An improved process for the preparation of tirzepatide
    发明人:SIRIPRAGADA MAHENDER RAO; GANDAVADI SUNIL KUMAR; PARUMANCHALA SHAIK SHAVALI; TELAKALA HEMA SUNDARA RAO; SHAIK KALESHA
    权利人:NEULAND LABORATORIES LTD
    摘要:An improved process for the preparation of Tirzepatide having the chemical structural Formula I. The present invention also relates to the compounds of SEQ ID NO. 1 to 14 or a pharmaceutically acceptable salt thereof for use in the synthesis of Tirzepatide or a pharmaceutically acceptable salt thereof. The present invention further relates to the intermediate compounds of Formulae II to Formulae XVIII and its process of preparation, which are used in the preparation of Tirzepatide or a pharmaceutically acceptable salt thereof.

    专利号:US-2018371021-A1
    优先权日:2017-05-11
    标 题 :Peptidomimetic macrocycles and uses thereof
    发明人:AIVADO MANUEL; GUERLAVAIS VINCENT; OLSON KAREN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    专利号:US-11091522-B2
    优先权日:2018-07-23
    标题 :Peptidomimetic macrocycles and uses thereof
    发明人:AIVADO MANUEL; GUERLAVAIS VINCENT; OLSON KAREN; ANNIS DAVID ALLEN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Biochemical Pharmacology., 5(108), 1960 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知